Sun Pharmaceutical and Industries, the fourth largest generic maker India, has posted a 17% drop in the consolidated profits in the third quarter for the financial year 2010 compared to the similar period a year ago, owing to lower sales volumed in US market.

Indoco Remedies Ltd., a Mumbai-based generic company, has announced a technology licensing agreement to produce generics with   Watson Pharmaceuticals, Inc.

NTx-265, a new therapy regimen to stimaulate patients' own stem cells to deal with severe traumatic brain injury by Stem Cell Therapeutics Corp has been given a No Objection Letter (NOL) by Health Canada.

A tobacco-based vaccine to treat non-Hodgkin’s lymphoma developed by Bayer is currently undergoing early-phase human studies.

Didanosine, the common drug used in the treatment of HIV/AIDS infection can lead to serious complications in liver, warned US FDA.